October 7, 2022
Jacqueline Miller, Senior Vice President and Therapeutic Area Head, Infectious Diseases, Moderna Moderna is currently investigating with its COVID-19 vaccine Spikevax whether people who have more reports of adverse reactions exhibit high antibody responses, Jacqueline Miller, the company’s senior vice...read more